🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and tolerability of ascending multiple oral doses of S...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00479349
Treatments Being Tested
The primary purpose of the study is to assess whether SAM-531, an investiga...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00481520
To assess the safety and tolerability of ascending single oral doses of SAM...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00479297
Treatments Being Tested
Primary: To evaluate the pharmacologic effect of single doses of SAM-531 on...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00519298
The purpose of this study is to evaluate the effects of multiple doses of v...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00745576
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of G...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00966966
Treatments Being Tested
To assess the safety and tolerability of ascending single oral doses of SAM...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00479700
Treatments Being Tested
The main objectives of this study is to assess the safety and tolerability ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00726115
The purpose of this study is to evaluate the relationship between plasma dr...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01253655
Treatments Being Tested
The study will evaluate the efficacy and safety of an investigational drug ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-05
Trial ID
NCT00895895
Treatments Being Tested